Global Over the Counter (OTC) drugs market stood at USD154.01 billion in 2020 and is expected to grow at a CAGR of around 9.86% during the forecast period. This can be attributed to the growing inclination of pharmaceutical companies towards OTC drugs from prescription (Rx) drugs. This in turn is expected to positively influence the market growth through 2026. Additionally, factors such as easy availability, low cost, no need of prescription to buy these drugs, among others are further expected to foster the market growth in the next few years. Besides, increasing disposable income of population coupled with increasing healthcare expenditure is further expected to drive the market growth over the next few years. Furthermore, growing awareness pertaining to diseases and maintaining a healthy lifestyle and health among the population worldwide has led to an increase in self-directed consumers who are majorly buying OTC products, thereby fueling the market growth. Also, the growing importance of dietary supplements is further expected to support the market growth in the next five years.

The global over the counter (OTC) drugs market is segmented based on product, route of administration, dosage form, distribution channel, region, and company. In terms of product, the market can be categorized into cold, cough & flu, vitamins, minerals & supplements, analgesics, gastrointestinal products, dermatology products and others. The cold, cough & flu segment dominated the market in 2020 with an overall market share of 22.99% on account of increasing occurrence of common cold, cough & flu among the population due to seasonal variations. The vitamins, minerals & supplements segment also registered significant growth in 2020 on account of the pandemic crisis and fear of catching infection. Furthermore, rising vitamin deficiencies, increasing malnourished population, among others also have led to an increase in demand for vitamins, minerals & supplements. Also, increasing self-medication trend is further expected to support the segmental growth.

Regionally, North America is expected to dominate the global over the counter (OTC) drugs market on account of proper streamlining and regulatory scenario in the region with respect to over the counter drugs. This region is expected to increase its market share in the future, owing to the leading trend among pharmaceutical companies to switch from Rx to OTC drugs.

Major players operating in the global over the counter (OTC) drugs market include Johnson & Johnson, Bayer AG, Novartis AG, GlaxoSmithKline Plc.-Pfizer, Inc., Sanofi S.A., Perrigo Company Plc., Reckitt Benckiser Group Plc., Sun Pharmaceutical Industries Ltd., The Procter & Gamble Company, Teva Pharmaceutical Industries Limited, Dr. Reddy’s Laboratories Ltd., Zydus Takeda Healthcare Pvt. Ltd., Mylan NV, Cipla Ltd., Alkem Laboratories Limited, and others. The companies are developing advanced technologies and launching new products to stay competitive in the market. Other competitive strategies include mergers & acquisitions, partnerships, agreements, and new developments to expand their geographic reach and to increase their customer bases. For instance, in June 2021, Bayer AG announced the approval of its over-the-counter drug Astepro Allergy from USFDA for the treatment of runny nose, itchy nose, nasal congestion, among others.

Years considered for this report:

Historical Years: 2016-2019

Base Year: 2020

Estimated Year: 2021

Forecast Period: 2022-2026

Objective of the Study:

  • To analyze the historical growth in the market size of global over the counter (OTC) drugs market from 2016 to 2020.
  • To estimate and forecast the market size of global over the counter (OTC) drugs market from 2021 to 2026 and growth rate until 2026.
  • To classify and forecast global over the counter (OTC) drugs market based on product, dosage form, distribution channel, company and regional distribution.
  • To identify dominant region or segment in the global over the counter (OTC) drugs market.
  • To identify drivers and challenges for global over the counter (OTC) drugs market.
  • To examine competitive developments such as expansions, new product launches, mergers & acquisitions, etc., in global over the counter (OTC) drugs market.
  • To identify and analyze the profile of leading players operating in global over the counter (OTC) drugs market.
  • To identify key sustainable strategies adopted by market players in global over the counter (OTC) drugs market.

Click here to download the sample

TechSci Research performed both primary as well as exhaustive secondary research for this study. Initially, TechSci Research sourced a list of manufacturers across the globe. Subsequently, TechSci Research conducted primary research surveys with the identified companies. While interviewing, the respondents were also enquired about their competitors. Through this technique, TechSci Research could include the hospitals/clinics which could not be identified due to the limitations of secondary research. TechSci Research analyzed the products and presence of all major players across the globe.

TechSci Research calculated the market size of global over the counter (OTC) drugs market using a bottom-up approach, wherein data for various end-user segments was recorded and forecast for the future years. TechSci Research sourced these values from the industry experts and company representatives and externally validated through analyzing historical data of these services and applications for getting an appropriate, overall market size. Various secondary sources such as company websites, news articles, press releases, company annual reports, investor presentations and financial reports were also studied by TechSci Research.

Key Target Audience:

  • Over the counter (OTC) drugs manufacturers, suppliers and other stakeholders
  • Government bodies such as regulating authorities and policy makers
  • Organizations, forums and alliances related to over the counter (OTC) drugs
  • Market research and consulting firms

The study is useful in providing answers to several critical questions that are important for the industry stakeholders such as manufacturers, suppliers, partners, end users, etc., besides allowing them in strategizing investments and capitalizing on market opportunities.

Report Scope:

In this report, global over the counter (OTC) drugs market has been segmented into following categories, in addition to the industry trends which have also been detailed below:

  • Over the Counter (OTC) Drugs Market, By Product:
    • Cough, Cold, & Flu,
    • Vitamins, Mineral, & Supplements (VMS)
    • Analgesics
    • Gastrointestinal Products
    • Dermatology Products
    • Others
  • Over the Counter (OTC) Drugs Market, By Route of Administration:
    • Oral
    • Parenteral
    • Topical
    • Others
  • Over the Counter (OTC) Drugs Market, By Dosage Form:
    • Tablets
    • Capsules
    • Liquids & Solutions
    • Cream/Lotion/Ointments
    • Others
  • Over the Counter (OTC) Drugs Market, By Distribution Channel:
    • Retail Pharmacy
    • Hospital Pharmacy
    • E-Pharmacy
  • Over the Counter (OTC) Drugs Market, By Region:
    • North America
      • United States
      • Canada
      • Mexico
    • Europe
      • Germany
      • United Kingdom
      • Italy
      • Spain
      • France
    • Asia-Pacific
      • China
      • India
      • Japan
      • Australia
      • South Korea
    • South America
      • Brazil
      • Argentina
      • Colombia
    • Middle East & Africa
      • Saudi Arabia
      • South Africa
      • UAE
      • Kuwait

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in global over the counter (OTC) drugs market.

Available Customizations:

With the given market data, TechSci Research offers customizations according to a company’s specific needs. The following customization options are available for the report:

Company Information

Detailed analysis and profiling of additional market players (up to five).

In case you don’t find what you are looking for, please get in touch with our custom research team at sales@techsciresearch.com

1.    Product Overview

2.    Research Methodology

3.    Impact of COVID-19 on Global Over the Counter (OTC) Drugs Market

4.    Executive Summary

5.    Voice of Customer

5.1.  Brand Awareness

5.2.  Commonly Sold Over the Counter (OTC) Drugs, By Product

5.3.  Preferred Point of Purchase

5.4.  Unmet Needs/Challenges

6.    Global Over the Counter (OTC) Drugs Market Outlook

6.1.  Market Size & Forecast

6.1.1.     By Value & Volume

6.2.  Market Share & Forecast

6.2.1.     By Product (Cough, Cold & Flu, Vitamins, Mineral, and Supplements (VMS), Analgesics, Gastrointestinal Products, Dermatology Products, Others)

6.2.2.     By Route of Administration (Oral, Parenteral, Topical, Others)

6.2.3.     By Dosage Form (Tablets, Capsules, Liquids & Solutions, Cream/Lotion/Ointments, Others)

6.2.4.     By Distribution Channel (Retail Pharmacy, Hospital Pharmacy, E-Pharmacy)

6.2.5.     By Region

6.2.6.     By Company (2020)

6.3.  Product Market Map

7.    North America Over the Counter (OTC) Drugs Market Outlook

7.1.  Market Size & Forecast          

7.1.1.     By Value & Volume

7.2.  Market Share & Forecast

7.2.1.     By Product

7.2.2.     By Route of Administration

7.2.3.     By Dosage Form

7.2.4.     By Distribution Channel

7.2.5.     By Country

7.3.  North America: Country Analysis

7.3.1.     United States Over the Counter (OTC) Drugs Market Outlook

7.3.1.1.         Market Size & Forecast

7.3.1.1.1.             By Value

7.3.1.2.         Market Share & Forecast

7.3.1.2.1.             By Product

7.3.1.2.2.             By Route of Administration

7.3.1.2.3.             By Dosage Form

7.3.1.2.4.             By Distribution Channel

7.3.2.     Canada Over the Counter (OTC) Drugs Market Outlook

7.3.2.1.         Market Size & Forecast

7.3.2.1.1.             By Value

7.3.2.2.         Market Share & Forecast

7.3.2.2.1.             By Product

7.3.2.2.2.             By Route of Administration

7.3.2.2.3.             By Dosage Form

7.3.2.2.4.             By Distribution Channel

7.3.3.     Mexico Over the Counter (OTC) Drugs Market Outlook

7.3.3.1.         Market Size & Forecast

7.3.3.1.1.             By Value

7.3.3.2.         Market Share & Forecast

7.3.3.2.1.             By Product

7.3.3.2.2.             By Route of Administration

7.3.3.2.3.             By Dosage Form

7.3.3.2.4.             By Distribution Channel

8.    Europe Over the Counter (OTC) Drugs Market Outlook

8.1.  Market Size & Forecast          

8.1.1.     By Value & Volume

8.2.  Market Share & Forecast

8.2.1.     By Product

8.2.2.     By Route of Administration

8.2.3.     By Dosage Form

8.2.4.     By Distribution Channel

8.2.5.     By Country

8.3.  Europe: Country Analysis

8.3.1.     Germany Over the Counter (OTC) Drugs Market Outlook

8.3.1.1.         Market Size & Forecast

8.3.1.1.1.             By Value

8.3.1.2.         Market Share & Forecast

8.3.1.2.1.             By Product

8.3.1.2.2.             By Route of Administration

8.3.1.2.3.             By Dosage Form

8.3.1.2.4.             By Distribution Channel

8.3.2.     United Kingdom Over the Counter (OTC) Drugs Market Outlook

8.3.2.1.         Market Size & Forecast

8.3.2.1.1.             By Value

8.3.2.2.         Market Share & Forecast

8.3.2.2.1.             By Product

8.3.2.2.2.             By Route of Administration

8.3.2.2.3.             By Dosage Form

8.3.2.2.4.             By Distribution Channel

8.3.3.     Italy Over the Counter (OTC) Drugs Market Outlook

8.3.3.1.         Market Size & Forecast

8.3.3.1.1.             By Value

8.3.3.2.         Market Share & Forecast

8.3.3.2.1.             By Product

8.3.3.2.2.             By Route of Administration

8.3.3.2.3.             By Dosage Form

8.3.3.2.4.             By Distribution Channel

8.3.4.     Spain Over the Counter (OTC) Drugs Market Outlook

8.3.4.1.         Market Size & Forecast

8.3.4.1.1.             By Value

8.3.4.2.         Market Share & Forecast

8.3.4.2.1.             By Product

8.3.4.2.2.             By Route of Administration

8.3.4.2.3.             By Dosage Form

8.3.4.2.4.             By Distribution Channel

8.3.5.     France Over the Counter (OTC) Drugs Market Outlook

8.3.5.1.         Market Size & Forecast

8.3.5.1.1.             By Value

8.3.5.2.         Market Share & Forecast

8.3.5.2.1.             By Product

8.3.5.2.2.             By Route of Administration

8.3.5.2.3.             By Dosage Form

8.3.5.2.4.             By Distribution Channel

9.    Asia-Pacific Over the Counter (OTC) Drugs Market Outlook

9.1.  Market Size & Forecast          

9.1.1.     By Value & Volume

9.2.  Market Share & Forecast

9.2.1.     By Product

9.2.2.     By Route of Administration

9.2.3.     By Dosage Form

9.2.4.     By Distribution Channel

9.2.5.     By Country

9.3.  Asia-Pacific: Country Analysis

9.3.1.     China Over the Counter (OTC) Drugs Market Outlook

9.3.1.1.         Market Size & Forecast

9.3.1.1.1.             By Value

9.3.1.2.         Market Share & Forecast

9.3.1.2.1.             By Product

9.3.1.2.2.             By Route of Administration

9.3.1.2.3.             By Dosage Form

9.3.1.2.4.             By Distribution Channel

9.3.2.     India Over the Counter (OTC) Drugs Market Outlook

9.3.2.1.         Market Size & Forecast

9.3.2.1.1.             By Value

9.3.2.2.         Market Share & Forecast

9.3.2.2.1.             By Product

9.3.2.2.2.             By Route of Administration

9.3.2.2.3.             By Dosage Form

9.3.2.2.4.             By Distribution Channel

9.3.3.     Japan Over the Counter (OTC) Drugs Market Outlook

9.3.3.1.         Market Size & Forecast

9.3.3.1.1.             By Value

9.3.3.2.         Market Share & Forecast

9.3.3.2.1.             By Product

9.3.3.2.2.             By Route of Administration

9.3.3.2.3.             By Dosage Form

9.3.3.2.4.             By Distribution Channel

9.3.4.     Australia Over the Counter (OTC) Drugs Market Outlook

9.3.4.1.         Market Size & Forecast

9.3.4.1.1.             By Value

9.3.4.2.         Market Share & Forecast

9.3.4.2.1.             By Product

9.3.4.2.2.             By Route of Administration

9.3.4.2.3.             By Dosage Form

9.3.4.2.4.             By Distribution Channel

9.3.5.     South Korea Over the Counter (OTC) Drugs Market Outlook

9.3.5.1.         Market Size & Forecast

9.3.5.1.1.             By Value

9.3.5.2.         Market Share & Forecast

9.3.5.2.1.             By Product

9.3.5.2.2.             By Route of Administration

9.3.5.2.3.             By Dosage Form

9.3.5.2.4.             By Distribution Channel

10.  South America Over the Counter (OTC) Drugs Market Outlook

10.1.              Market Size & Forecast

10.1.1.  By Value & Volume

10.2.              Market Share & Forecast

10.2.1.  By Product

10.2.2.  By Route of Administration

10.2.3.  By Dosage Form

10.2.4.  By Distribution Channel

10.2.5.  By Country

10.3.              South America: Country Analysis

10.3.1.  Brazil Over the Counter (OTC) Drugs Market Outlook

10.3.1.1.      Market Size & Forecast

10.3.1.1.1.           By Value

10.3.1.2.      Market Share & Forecast

10.3.1.2.1.           By Product

10.3.1.2.2.           By Route of Administration

10.3.1.2.3.           By Dosage Form

10.3.1.2.4.           By Distribution Channel

10.3.2.  Argentina Over the Counter (OTC) Drugs Market Outlook

10.3.2.1.      Market Size & Forecast

10.3.2.1.1.           By Value

10.3.2.2.      Market Share & Forecast

10.3.2.2.1.           By Product

10.3.2.2.2.           By Route of Administration

10.3.2.2.3.           By Dosage Form

10.3.2.2.4.           By Distribution Channel

10.3.3.  Colombia Over the Counter (OTC) Drugs Market Outlook

10.3.3.1.      Market Size & Forecast

10.3.3.1.1.           By Value

10.3.3.2.      Market Share & Forecast

10.3.3.2.1.           By Product

10.3.3.2.2.           By Route of Administration

10.3.3.2.3.           By Dosage Form

10.3.3.2.4.           By Distribution Channel

11.  Middle East and Africa Over the Counter (OTC) Drugs Market Outlook

11.1.              Market Size & Forecast

11.1.1.  By Value & Volume

11.2.              Market Share & Forecast

11.2.1.  By Product

11.2.2.  By Route of Administration

11.2.3.  By Dosage Form

11.2.4.  By Distribution Channel

11.2.5.  By Country

11.3.              MEA: Country Analysis

11.3.1.  Saudi Arabia Over the Counter (OTC) Drugs Market Outlook

11.3.1.1.      Market Size & Forecast

11.3.1.1.1.           By Value

11.3.1.2.      Market Share & Forecast

11.3.1.2.1.           By Product

11.3.1.2.2.           By Route of Administration

11.3.1.2.3.           By Dosage Form

11.3.1.2.4.           By Distribution Channel

11.3.2.  South Africa Over the Counter (OTC) Drugs Market Outlook

11.3.2.1.      Market Size & Forecast

11.3.2.1.1.           By Value

11.3.2.2.      Market Share & Forecast

11.3.2.2.1.           By Product

11.3.2.2.2.           By Route of Administration

11.3.2.2.3.           By Dosage Form

11.3.2.2.4.           By Distribution Channel

11.3.3.  UAE Over the Counter (OTC) Drugs Market Outlook

11.3.3.1.      Market Size & Forecast

11.3.3.1.1.           By Value

11.3.3.2.      Market Share & Forecast

11.3.3.2.1.           By Product

11.3.3.2.2.           By Route of Administration

11.3.3.2.3.           By Dosage Form

11.3.3.2.4.           By Distribution Channel

11.3.4.  Kuwait Over the Counter (OTC) Drugs Market Outlook

11.3.4.1.      Market Size & Forecast

11.3.4.1.1.           By Value

11.3.4.2.      Market Share & Forecast

11.3.4.2.1.           By Product

11.3.4.2.2.           By Route of Administration

11.3.4.2.3.           By Dosage Form

11.3.4.2.4.           By Distribution Channel

12.  Market Dynamics

12.1.              Drivers

12.2.              Challenges

13.  Market Trends and Developments

14.  Competitive Landscape

14.1.              Johnson & Johnson

14.2.              Bayer AG

14.3.              Novartis AG

14.4.              GlaxoSmithKline Plc.-Pfizer, Inc.

14.5.              Sanofi S.A.

14.6.              Perrigo Company Plc.

14.7.              Reckitt Benckiser Group Plc.

14.8.              Sun Pharmaceutical Industries Ltd.

14.9.              The Procter & Gamble Company

14.10.            Teva Pharmaceutical Industries Limited

14.11.            Dr. Reddy’s Laboratories Ltd.

14.12.            Zydus Takeda Healthcare Pvt. Ltd.

14.13.            Mylan NV

14.14.            Cipla Ltd.

14.15.            Alkem Laboratories Limited

15.  Strategic Recommendations

16.  About Us & Disclaimer

In case you don’t find what you are looking for, please get in touch with our custom research team at sales@techsciresearch.com

  • Figure 1: Global Over the Counter (OTC) Drugs Market Size, By Value (USD Billion), 2016-2026F

    Figure 2: Global Over the Counter (OTC) Drugs Market Size, By Volume (Billion Units), 2016-2026F

    Figure 3: Global Over the Counter (OTC) Drugs Market Share, By Product, By Value, 2016-2026F

    Figure 4: Global Over the Counter (OTC) Drugs Market Share, By Route of Administration, By Value, 2016-2026F

    Figure 5: Global Over the Counter (OTC) Drugs Market Share, By Dosage Form, By Value, 2016-2026F

    Figure 6: Global Over the Counter (OTC) Drugs Market Share, By Distribution Channel, By Value, 2016-2026F

    Figure 7: Global Over the Counter (OTC) Drugs Market Share, By Region, By Value, 2016-2026F

    Figure 8: Global Over the Counter (OTC) Drugs Market Share, By Company, By Value, 2020

    Figure 9: North America Over the Counter (OTC) Drugs Market Size, By Value (USD Billion), 2016-2026F

    Figure 10: North America Over the Counter (OTC) Drugs Market Size, By Volume (Billion Units), 2016-2026F

    Figure 11: North America Over the Counter (OTC) Drugs Market Share, By Product, By Value, 2016-2026F

    Figure 12: North America Over the Counter (OTC) Drugs Market Share, By Route of Administration, By Value, 2016-2026F

    Figure 13: North America Over the Counter (OTC) Drugs Market Share, By Dosage Form, By Value, 2016-2026F

    Figure 14: North America Over the Counter (OTC) Drugs Market Share, By Distribution Channel, By Value, 2016-2026F

    Figure 15: North America Over the Counter (OTC) Drugs Market Share, By Country, By Value, 2016-2026F

    Figure 16: United States Over the Counter (OTC) Drugs Market Size, By Value (USD Billion), 2016-2026F

    Figure 17: United States Over the Counter (OTC) Drugs Market Share, By Product, By Value, 2016-2026F

    Figure 18: United States Over the Counter (OTC) Drugs Market Share, By Route of Administration, By Value, 2016-2026F

    Figure 19: United States Over the Counter (OTC) Drugs Market Share, By Dosage Form, By Value, 2016-2026F

    Figure 20: United States Over the Counter (OTC) Drugs Market Share, By Distribution Channel, By Value, 2016-2026F

    Figure 21: Canada Over the Counter (OTC) Drugs Market Size, By Value (USD Billion), 2016-2026F

    Figure 22: Canada Over the Counter (OTC) Drugs Market Share, By Product, By Value, 2016-2026F

    Figure 23: Canada Over the Counter (OTC) Drugs Market Share, By Route of Administration, By Value, 2016-2026F

    Figure 24: Canada Over the Counter (OTC) Drugs Market Share, By Dosage Form, By Value, 2016-2026F

    Figure 25: Canada Over the Counter (OTC) Drugs Market Share, By Distribution Channel, By Value, 2016-2026F

    Figure 26: Mexico Over the Counter (OTC) Drugs Market Size, By Value (USD Billion), 2016-2026F

    Figure 27: Mexico Over the Counter (OTC) Drugs Market Share, By Product, By Value, 2016-2026F

    Figure 28: Mexico Over the Counter (OTC) Drugs Market Share, By Route of Administration, By Value, 2016-2026F

    Figure 29: Mexico Over the Counter (OTC) Drugs Market Share, By Dosage Form, By Value, 2016-2026F

    Figure 30: Mexico Over the Counter (OTC) Drugs Market Share, By Distribution Channel, By Value, 2016-2026F

    Figure 31: Europe Over the Counter (OTC) Drugs Market Size, By Value (USD Billion), 2016-2026F

    Figure 32: Europe Over the Counter (OTC) Drugs Market Size, By Volume (Billion Units), 2016-2026F

    Figure 33: Europe Over the Counter (OTC) Drugs Market Share, By Product, By Value, 2016-2026F

    Figure 34: Europe Over the Counter (OTC) Drugs Market Share, By Route of Administration, By Value, 2016-2026F

    Figure 35: Europe Over the Counter (OTC) Drugs Market Share, By Dosage Form, By Value, 2016-2026F

    Figure 36: Europe Over the Counter (OTC) Drugs Market Share, By Distribution Channel, By Value, 2016-2026F

    Figure 37: Europe Over the Counter (OTC) Drugs Market Share, By Country, By Value, 2016-2026F

    Figure 38: Germany Over the Counter (OTC) Drugs Market Size, By Value (USD Billion), 2016-2026F

    Figure 39: Germany Over the Counter (OTC) Drugs Market Share, By Product, By Value, 2016-2026F

    Figure 40: Germany Over the Counter (OTC) Drugs Market Share, By Route of Administration, By Value, 2016-2026F

    Figure 41: Germany Over the Counter (OTC) Drugs Market Share, By Dosage Form, By Value, 2016-2026F

    Figure 42: Germany Over the Counter (OTC) Drugs Market Share, By Distribution Channel, By Value, 2016-2026F

    Figure 43: United Kingdom Over the Counter (OTC) Drugs Market Size, By Value (USD Billion), 2016-2026F

    Figure 44: United Kingdom Over the Counter (OTC) Drugs Market Share, By Product, By Value, 2016-2026F

    Figure 45: United Kingdom Over the Counter (OTC) Drugs Market Share, By Route of Administration, By Value, 2016-2026F

    Figure 46: United Kingdom Over the Counter (OTC) Drugs Market Share, By Dosage Form, By Value, 2016-2026F

    Figure 47: United Kingdom Over the Counter (OTC) Drugs Market Share, By Distribution Channel, By Value, 2016-2026F

    Figure 48: Italy Over the Counter (OTC) Drugs Market Size, By Value (USD Billion), 2016-2026F

    Figure 49: Italy Over the Counter (OTC) Drugs Market Share, By Product, By Value, 2016-2026F

    Figure 50: Italy Over the Counter (OTC) Drugs Market Share, By Route of Administration, By Value, 2016-2026F

    Figure 51: Italy Over the Counter (OTC) Drugs Market Share, By Dosage Form, By Value, 2016-2026F

    Figure 52: Italy Over the Counter (OTC) Drugs Market Share, By Distribution Channel, By Value, 2016-2026F

    Figure 53: Spain Over the Counter (OTC) Drugs Market Size, By Value (USD Billion), 2016-2026F

    Figure 54: Spain Over the Counter (OTC) Drugs Market Share, By Product, By Value, 2016-2026F

    Figure 55: Spain Over the Counter (OTC) Drugs Market Share, By Route of Administration, By Value, 2016-2026F

    Figure 56: Spain Over the Counter (OTC) Drugs Market Share, By Dosage Form, By Value, 2016-2026F

    Figure 57: Spain Over the Counter (OTC) Drugs Market Share, By Distribution Channel, By Value, 2016-2026F

    Figure 58: France Over the Counter (OTC) Drugs Market Size, By Value (USD Billion), 2016-2026F

    Figure 59: France Over the Counter (OTC) Drugs Market Share, By Product, By Value, 2016-2026F

    Figure 60: France Over the Counter (OTC) Drugs Market Share, By Route of Administration, By Value, 2016-2026F

    Figure 61: France Over the Counter (OTC) Drugs Market Share, By Dosage Form, By Value, 2016-2026F

    Figure 62: France Over the Counter (OTC) Drugs Market Share, By Distribution Channel, By Value, 2016-2026F

    Figure 63: Asia Pacific Over the Counter (OTC) Drugs Market Size, By Value (USD Billion), 2016-2026F

    Figure 64: Asia Pacific Over the Counter (OTC) Drugs Market Size, By Volume (Billion Units), 2016-2026F

    Figure 65: Asia Pacific Over the Counter (OTC) Drugs Market Share, By Product, By Value, 2016-2026F

    Figure 66: Asia Pacific Over the Counter (OTC) Drugs Market Share, By Route of Administration, By Value, 2016-2026F

    Figure 67: Asia Pacific Over the Counter (OTC) Drugs Market Share, By Dosage Form, By Value, 2016-2026F

    Figure 68: Asia Pacific Over the Counter (OTC) Drugs Market Share, By Distribution Channel, By Value, 2016-2026F

    Figure 69: Asia Pacific Over the Counter (OTC) Drugs Market Share, By Country, By Value, 2016-2026F

    Figure 70: China Over the Counter (OTC) Drugs Market Size, By Value (USD Billion), 2016-2026F

    Figure 71: China Over the Counter (OTC) Drugs Market Share, By Product, By Value, 2016-2026F

    Figure 72: China Over the Counter (OTC) Drugs Market Share, By Route of Administration, By Value, 2016-2026F

    Figure 73: China Over the Counter (OTC) Drugs Market Share, By Dosage Form, By Value, 2016-2026F

    Figure 74: China Over the Counter (OTC) Drugs Market Share, By Distribution Channel, By Value, 2016-2026F

    Figure 75: India Over the Counter (OTC) Drugs Market Size, By Value (USD Billion), 2016-2026F

    Figure 76: India Over the Counter (OTC) Drugs Market Share, By Product, By Value, 2016-2026F

    Figure 77: India Over the Counter (OTC) Drugs Market Share, By Route of Administration, By Value, 2016-2026F

    Figure 78: India Over the Counter (OTC) Drugs Market Share, By Dosage Form, By Value, 2016-2026F

    Figure 79: India Over the Counter (OTC) Drugs Market Share, By Distribution Channel, By Value, 2016-2026F

    Figure 80: Japan Over the Counter (OTC) Drugs Market Size, By Value (USD Billion), 2016-2026F

    Figure 81: Japan Over the Counter (OTC) Drugs Market Share, By Product, By Value, 2016-2026F

    Figure 82: Japan Over the Counter (OTC) Drugs Market Share, By Route of Administration, By Value, 2016-2026F

    Figure 83: Japan Over the Counter (OTC) Drugs Market Share, By Dosage Form, By Value, 2016-2026F

    Figure 84: Japan Over the Counter (OTC) Drugs Market Share, By Distribution Channel, By Value, 2016-2026F

    Figure 85: Australia Over the Counter (OTC) Drugs Market Size, By Value (USD Billion), 2016-2026F

    Figure 86: Australia Over the Counter (OTC) Drugs Market Share, By Product, By Value, 2016-2026F

    Figure 87: Australia Over the Counter (OTC) Drugs Market Share, By Route of Administration, By Value, 2016-2026F

    Figure 88: Australia Over the Counter (OTC) Drugs Market Share, By Dosage Form, By Value, 2016-2026F

    Figure 89: Australia Over the Counter (OTC) Drugs Market Share, By Distribution Channel, By Value, 2016-2026F

    Figure 90: South Korea Over the Counter (OTC) Drugs Market Size, By Value (USD Billion), 2016-2026F

    Figure 91: South Korea Over the Counter (OTC) Drugs Market Share, By Product, By Value, 2016-2026F

    Figure 92: South Korea Over the Counter (OTC) Drugs Market Share, By Route of Administration, By Value, 2016-2026F

    Figure 93: South Korea Over the Counter (OTC) Drugs Market Share, By Dosage Form, By Value, 2016-2026F

    Figure 94: South Korea Over the Counter (OTC) Drugs Market Share, By Distribution Channel, By Value, 2016-2026F

    Figure 95: South America Over the Counter (OTC) Drugs Market Size, By Value (USD Billion), 2016-2026F

    Figure 96: South America Over the Counter (OTC) Drugs Market Size, By Volume (Billion Units), 2016-2026F

    Figure 97: South America Over the Counter (OTC) Drugs Market Share, By Product, By Value, 2016-2026F

    Figure 98: South America Over the Counter (OTC) Drugs Market Share, By Route of Administration, By Value, 2016-2026F

    Figure 99: South America Over the Counter (OTC) Drugs Market Share, By Dosage Form, By Value, 2016-2026F

    Figure 100: South America Over the Counter (OTC) Drugs Market Share, By Distribution Channel, By Value, 2016-2026F

    Figure 101: South America Over the Counter (OTC) Drugs Market Share, By Country, By Value, 2016-2026F

    Figure 102: Brazil Over the Counter (OTC) Drugs Market Size, By Value (USD Billion), 2016-2026F

    Figure 103: Brazil Over the Counter (OTC) Drugs Market Share, By Product, By Value, 2016-2026F

    Figure 104: Brazil Over the Counter (OTC) Drugs Market Share, By Route of Administration, By Value, 2016-2026F

    Figure 105: Brazil Over the Counter (OTC) Drugs Market Share, By Dosage Form, By Value, 2016-2026F

    Figure 106: Brazil Over the Counter (OTC) Drugs Market Share, By Distribution Channel, By Value, 2016-2026F

    Figure 107: Argentina Over the Counter (OTC) Drugs Market Size, By Value (USD Billion), 2016-2026F

    Figure 108: Argentina Over the Counter (OTC) Drugs Market Share, By Product, By Value, 2016-2026F

    Figure 109: Argentina Over the Counter (OTC) Drugs Market Share, By Route of Administration, By Value, 2016-2026F

    Figure 110: Argentina Over the Counter (OTC) Drugs Market Share, By Dosage Form, By Value, 2016-2026F

    Figure 111: Argentina Over the Counter (OTC) Drugs Market Share, By Distribution Channel, By Value, 2016-2026F

    Figure 112: Colombia Over the Counter (OTC) Drugs Market Size, By Value (USD Billion), 2016-2026F

    Figure 113: Colombia Over the Counter (OTC) Drugs Market Share, By Product, By Value, 2016-2026F

    Figure 114: Colombia Over the Counter (OTC) Drugs Market Share, By Route of Administration, By Value, 2016-2026F

    Figure 115: Colombia Over the Counter (OTC) Drugs Market Share, By Dosage Form, By Value, 2016-2026F

    Figure 116: Colombia Over the Counter (OTC) Drugs Market Share, By Distribution Channel, By Value, 2016-2026F

    Figure 117: Middle East & Africa Over the Counter (OTC) Drugs Market Size, By Value (USD Billion), 2016-2026F

    Figure 118: Middle East & Africa Over the Counter (OTC) Drugs Market Size, By Volume (Billion Units), 2016-2026F

    Figure 119: Middle East & Africa Over the Counter (OTC) Drugs Market Share, By Product, By Value, 2016-2026F

    Figure 120: Middle East & Africa Over the Counter (OTC) Drugs Market Share, By Route of Administration, By Value, 2016-2026F

    Figure 121: Middle East & Africa Over the Counter (OTC) Drugs Market Share, By Dosage Form, By Value, 2016-2026F

    Figure 122: Middle East & Africa Over the Counter (OTC) Drugs Market Share, By Distribution Channel, By Value, 2016-2026F

    Figure 123: Middle East & Africa Over the Counter (OTC) Drugs Market Share, By Country, By Value, 2016-2026F

    Figure 124: Saudi Arabia Over the Counter (OTC) Drugs Market Size, By Value (USD Billion), 2016-2026F

    Figure 125: Saudi Arabia Over the Counter (OTC) Drugs Market Share, By Product, By Value, 2016-2026F

    Figure 126: Saudi Arabia Over the Counter (OTC) Drugs Market Share, By Route of Administration, By Value, 2016-2026F

    Figure 127: Saudi Arabia Over the Counter (OTC) Drugs Market Share, By Dosage Form, By Value, 2016-2026F

    Figure 128: Saudi Arabia Over the Counter (OTC) Drugs Market Share, By Distribution Channel, By Value, 2016-2026F

    Figure 129: South Africa Over the Counter (OTC) Drugs Market Size, By Value (USD Billion), 2016-2026F

    Figure 130: South Africa Over the Counter (OTC) Drugs Market Share, By Product, By Value, 2016-2026F

    Figure 131: South Africa Over the Counter (OTC) Drugs Market Share, By Route of Administration, By Value, 2016-2026F

    Figure 132: South Africa Over the Counter (OTC) Drugs Market Share, By Dosage Form, By Value, 2016-2026F

    Figure 133: South Africa Over the Counter (OTC) Drugs Market Share, By Distribution Channel, By Value, 2016-2026F

    Figure 134: UAE Over the Counter (OTC) Drugs Market Size, By Value (USD Billion), 2016-2026F

    Figure 135: UAE Over the Counter (OTC) Drugs Market Share, By Product, By Value, 2016-2026F

    Figure 136: UAE Over the Counter (OTC) Drugs Market Share, By Route of Administration, By Value, 2016-2026F

    Figure 137: UAE Over the Counter (OTC) Drugs Market Share, By Dosage Form, By Value, 2016-2026F

    Figure 138: UAE Over the Counter (OTC) Drugs Market Share, By Distribution Channel, By Value, 2016-2026F

    Figure 139: Kuwait Over the Counter (OTC) Drugs Market Size, By Value (USD Billion), 2016-2026F

    Figure 140: Kuwait Over the Counter (OTC) Drugs Market Share, By Product, By Value, 2016-2026F

    Figure 141: Kuwait Over the Counter (OTC) Drugs Market Share, By Route of Administration, By Value, 2016-2026F

    Figure 142: Kuwait Over the Counter (OTC) Drugs Market Share, By Dosage Form, By Value, 2016-2026F

    Figure 143: Kuwait Over the Counter (OTC) Drugs Market Share, By Distribution Channel, By Value, 2016-2026F